313
Views
1
CrossRef citations to date
0
Altmetric
Review

Review of invasive meningococcal disease during the last 40 years in Turkey

&
Pages 1089-1097 | Published online: 01 Jul 2015
 

Abstract

Due to the lack of comprehensive surveillance data representing Turkey, the authors aimed to derive information by panoramically reviewing all articles related to invasive meningococcal disease (IMD) published in the last 40 years. The following databases were reviewed: Ulakbim (the national database), BIOSIS Previews (from 1995), Evidence-Based Medicine Reviews-Cochrane Database of Systematic Reviews (from 2005), Embase (from 1996), Ovid MEDLINE(R) (from 1946) and Journals@Ovid Full Text (2014). Twenty-seven articles, 10 published in international journals and 17 in national journals, were identified. Only two were multicenter sentinel meningitis surveillance studies. Also, 74% of IMD patients were aged 5 years or younger and the median overall case fatality rate during childhood was 18.44%. Turkey is a country where meningococcal vaccination on a national basis is recommended by WHO. A vaccination strategy for serogroups B and W135 targeting the first 5 years, covering especially the first 12 months, would be appropriate.

Financial & competing interests disclosure

S Altinel was an employee at Novartis Vaccines & Diagnostics, Turkey, at the time of writing this review. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Key issues
  • Twenty-seven articles were identified from Turkey, 10 published in international journals and 17 in national journals between 1974 and 2014.

  • 74% of invasive meningococcal disease patients were aged 5 years or younger.

  • The median overall case fatality rate of meningococcal disease during childhood was calculated as 18.44%.

  • Active surveillance is critical in determining the epidemiology of invasive meningococcal disease.

  • Turkey is among the countries for which meningococcal vaccination on a national basis is recommended by WHO.

  • Vaccination strategy for serogroup B and W135 targeting the first 5 years, covering especially the first 12 months, may be required in Turkey.

  • Better surveillance is needed to guide the introduction of meningococcal vaccine for getting optimum benefit.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.